Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 221.201 | 85 |
GSM780708 | Untreated after 4 days (C2_1) | 173.616 | 82 |
GSM780709 | Untreated after 4 days (C3_1) | 146.035 | 80 |
GSM780719 | Untreated after 4 days (C1_2) | 231.771 | 85 |
GSM780720 | Untreated after 4 days (C2_2) | 214.104 | 84 |
GSM780721 | Untreated after 4 days (C3_2) | 166.185 | 82 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 166.522 | 82 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 198.798 | 83 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 237.825 | 85 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 171.169 | 82 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 216.044 | 84 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 265.306 | 86 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 157.316 | 81 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 168.298 | 82 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 181.113 | 83 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 179.235 | 82 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 179.9 | 82 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 185.198 | 83 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 214.284 | 84 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 174.971 | 82 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 223.011 | 85 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 197.128 | 83 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 224.957 | 85 |